Pharma & Healthcare
Global Biosimilar Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285532
- Pages: 132
- Figures: 124
- Views: 25
In 2024, the global market size of Biosimilar Drug was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product"s patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biosimilar Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Drug.
The Biosimilar Drug market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Segment by Type
Injection
Tablets
Other Types
Segment by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Biosimilar Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Biosimilar Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product"s patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biosimilar Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Drug.
The Biosimilar Drug market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Segment by Type
Injection
Tablets
Other Types
Segment by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Biosimilar Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Biosimilar Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Biosimilar Drug Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Drug Revenue 2020-2031
2.1.2 Global Biosimilar Drug Sales 2020-2031
2.2 Biosimilar Drug Market Size by Region: 2024 Versus 2031
2.3 Biosimilar Drug Sales by Region (2020-2031)
2.3.1 Global Biosimilar Drug Sales by Region: 2020-2025
2.3.2 Global Biosimilar Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Biosimilar Drug Sales Market Share by Region (2020-2031)
2.4 Biosimilar Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Biosimilar Drug Revenue by Region: 2020-2025
2.4.2 Global Biosimilar Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Biosimilar Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biosimilar Drug Sales by Type (2020-2031)
3.1.1.1 Global Biosimilar Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Biosimilar Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Biosimilar Drug Revenue by Type (2020-2031)
3.1.2.1 Global Biosimilar Drug Revenue by Type (2020-2031)
3.1.2.2 Global Biosimilar Drug Revenue Market Share by Type (2020-2031)
3.1.3 Biosimilar Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biosimilar Drug Sales by Application (2020-2031)
3.2.1.1 Global Biosimilar Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Biosimilar Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Biosimilar Drug Revenue by Application (2020-2031)
3.2.2.1 Global Biosimilar Drug Revenue by Application (2020-2031)
3.2.2.2 Global Biosimilar Drug Revenue Market Share by Application (2020-2031)
3.2.3 Biosimilar Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injection of Biosimilar Drug Revenue Market Share by Application
3.3.2 Tablets of Biosimilar Drug Revenue Market Share by Application
3.3.3 Other Types of Biosimilar Drug Revenue Market Share by Application
4 Global Biosimilar Drug by Manufacturers
4.1 Global Top Biosimilar Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Biosimilar Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Biosimilar Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Biosimilar Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Biosimilar Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Biosimilar Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Biosimilar Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Biosimilar Drug Manufacturing Base Distribution, Product Type
4.5.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Biosimilar Drug Market
4.5.3 Manufacturers Biosimilar Drug Product Type and Application
4.5.4 Injection Market Sales of Biosimilar Drug by Manufacturer
4.5.5 Tablets Market Sales of Biosimilar Drug by Manufacturer
4.5.6 Other Types Market Sales of Biosimilar Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CP Guojian Pharma
5.1.1 CP Guojian Pharma Company Information
5.1.2 CP Guojian Pharma Description, Business Overview
5.1.3 CP Guojian Pharma Biosimilar Drug Products Offered
5.1.4 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CP Guojian Pharma Biosimilar Drug Sales by Product in 2024
5.1.6 CP Guojian Pharma Biosimilar Drug Sales by Application in 2024
5.1.7 CP Guojian Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.1.8 CP Guojian Pharma Recent Developments
5.2 Biotech Pharma
5.2.1 Biotech Pharma Company Information
5.2.2 Biotech Pharma Description, Business Overview
5.2.3 Biotech Pharma Biosimilar Drug Products Offered
5.2.4 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Biotech Pharma Biosimilar Drug Sales by Product in 2024
5.2.6 Biotech Pharma Biosimilar Drug Sales by Application in 2024
5.2.7 Biotech Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.2.8 Biotech Pharma Recent Developments
5.3 Celgen Pharma
5.3.1 Celgen Pharma Company Information
5.3.2 Celgen Pharma Description, Business Overview
5.3.3 Celgen Pharma Biosimilar Drug Products Offered
5.3.4 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Celgen Pharma Biosimilar Drug Sales by Product in 2024
5.3.6 Celgen Pharma Biosimilar Drug Sales by Application in 2024
5.3.7 Celgen Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.3.8 Celgen Pharma Recent Developments
5.4 Henlius
5.4.1 Henlius Company Information
5.4.2 Henlius Description, Business Overview
5.4.3 Henlius Biosimilar Drug Products Offered
5.4.4 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Henlius Biosimilar Drug Sales by Product in 2024
5.4.6 Henlius Biosimilar Drug Sales by Application in 2024
5.4.7 Henlius Biosimilar Drug Sales by Geographic Area in 2024
5.4.8 Henlius Recent Developments
5.5 Amgen
5.5.1 Amgen Company Information
5.5.2 Amgen Description, Business Overview
5.5.3 Amgen Biosimilar Drug Products Offered
5.5.4 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Amgen Biosimilar Drug Sales by Product in 2024
5.5.6 Amgen Biosimilar Drug Sales by Application in 2024
5.5.7 Amgen Biosimilar Drug Sales by Geographic Area in 2024
5.5.8 Amgen Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Company Information
5.6.2 Eli Lilly Description, Business Overview
5.6.3 Eli Lilly Biosimilar Drug Products Offered
5.6.4 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Eli Lilly Biosimilar Drug Sales by Product in 2024
5.6.6 Eli Lilly Biosimilar Drug Sales by Application in 2024
5.6.7 Eli Lilly Biosimilar Drug Sales by Geographic Area in 2024
5.6.8 Eli Lilly Recent Developments
5.7 Sandoz
5.7.1 Sandoz Company Information
5.7.2 Sandoz Description, Business Overview
5.7.3 Sandoz Biosimilar Drug Products Offered
5.7.4 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Sandoz Biosimilar Drug Sales by Product in 2024
5.7.6 Sandoz Biosimilar Drug Sales by Application in 2024
5.7.7 Sandoz Biosimilar Drug Sales by Geographic Area in 2024
5.7.8 Sandoz Recent Developments
5.8 Changchun High Tech
5.8.1 Changchun High Tech Company Information
5.8.2 Changchun High Tech Description, Business Overview
5.8.3 Changchun High Tech Biosimilar Drug Products Offered
5.8.4 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Changchun High Tech Biosimilar Drug Sales by Product in 2024
5.8.6 Changchun High Tech Biosimilar Drug Sales by Application in 2024
5.8.7 Changchun High Tech Biosimilar Drug Sales by Geographic Area in 2024
5.8.8 Changchun High Tech Recent Developments
5.9 Innovent
5.9.1 Innovent Company Information
5.9.2 Innovent Description, Business Overview
5.9.3 Innovent Biosimilar Drug Products Offered
5.9.4 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Innovent Biosimilar Drug Sales by Product in 2024
5.9.6 Innovent Biosimilar Drug Sales by Application in 2024
5.9.7 Innovent Biosimilar Drug Sales by Geographic Area in 2024
5.9.8 Innovent Recent Developments
6 North America
6.1 North America Biosimilar Drug Market Size YoY Growth 2020-2031
6.2 North America Biosimilar Drug Market Facts & Figures by Country
6.2.1 North America Biosimilar Drug Sales by Country (2020-2031)
6.2.2 North America Biosimilar Drug Revenue by Country (2020-2031)
6.3 North America Biosimilar Drug Sales by Type (2020-2025)
6.4 North America Biosimilar Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biosimilar Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biosimilar Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Biosimilar Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Biosimilar Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Biosimilar Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Biosimilar Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Biosimilar Drug Market Size YoY Growth 2020-2031
8.2 Europe Biosimilar Drug Market Facts & Figures by Country
8.2.1 Europe Biosimilar Drug Sales by Country (2020-2031)
8.2.2 Europe Biosimilar Drug Revenue by Country (2020-2031)
8.3 Europe Biosimilar Drug Sales by Type (2020-2025)
8.4 Europe Biosimilar Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Biosimilar Drug Market Size YoY Growth 2020-2031
9.2 Latin America Biosimilar Drug Market Facts & Figures by Country
9.2.1 Latin America Biosimilar Drug Sales by Country (2020-2031)
9.2.2 Latin America Biosimilar Drug Revenue by Country (2020-2031)
9.3 Latin America Biosimilar Drug Sales by Type (2020-2025)
9.4 Latin America Biosimilar Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biosimilar Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Biosimilar Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Biosimilar Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Biosimilar Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Biosimilar Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biosimilar Drug Supply Chain Analysis
11.2 Biosimilar Drug Key Raw Materials and Upstream Suppliers
11.3 Biosimilar Drug Clients Analysis
11.4 Biosimilar Drug Sales Channel and Sales Model Analysis
11.4.1 Biosimilar Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biosimilar Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biosimilar Drug Distributors
12 Biosimilar Drug Market Dynamics
12.1 Biosimilar Drug Industry Trends
12.2 Biosimilar Drug Market Drivers
12.3 Biosimilar Drug Market Challenges
12.4 Biosimilar Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Biosimilar Drug Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Drug Revenue 2020-2031
2.1.2 Global Biosimilar Drug Sales 2020-2031
2.2 Biosimilar Drug Market Size by Region: 2024 Versus 2031
2.3 Biosimilar Drug Sales by Region (2020-2031)
2.3.1 Global Biosimilar Drug Sales by Region: 2020-2025
2.3.2 Global Biosimilar Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Biosimilar Drug Sales Market Share by Region (2020-2031)
2.4 Biosimilar Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Biosimilar Drug Revenue by Region: 2020-2025
2.4.2 Global Biosimilar Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Biosimilar Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Biosimilar Drug Sales by Type (2020-2031)
3.1.1.1 Global Biosimilar Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Biosimilar Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Biosimilar Drug Revenue by Type (2020-2031)
3.1.2.1 Global Biosimilar Drug Revenue by Type (2020-2031)
3.1.2.2 Global Biosimilar Drug Revenue Market Share by Type (2020-2031)
3.1.3 Biosimilar Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Biosimilar Drug Sales by Application (2020-2031)
3.2.1.1 Global Biosimilar Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Biosimilar Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Biosimilar Drug Revenue by Application (2020-2031)
3.2.2.1 Global Biosimilar Drug Revenue by Application (2020-2031)
3.2.2.2 Global Biosimilar Drug Revenue Market Share by Application (2020-2031)
3.2.3 Biosimilar Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injection of Biosimilar Drug Revenue Market Share by Application
3.3.2 Tablets of Biosimilar Drug Revenue Market Share by Application
3.3.3 Other Types of Biosimilar Drug Revenue Market Share by Application
4 Global Biosimilar Drug by Manufacturers
4.1 Global Top Biosimilar Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Biosimilar Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Biosimilar Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Biosimilar Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Biosimilar Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Biosimilar Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Biosimilar Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Biosimilar Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Biosimilar Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Biosimilar Drug Manufacturing Base Distribution, Product Type
4.5.1 Biosimilar Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Biosimilar Drug Market
4.5.3 Manufacturers Biosimilar Drug Product Type and Application
4.5.4 Injection Market Sales of Biosimilar Drug by Manufacturer
4.5.5 Tablets Market Sales of Biosimilar Drug by Manufacturer
4.5.6 Other Types Market Sales of Biosimilar Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CP Guojian Pharma
5.1.1 CP Guojian Pharma Company Information
5.1.2 CP Guojian Pharma Description, Business Overview
5.1.3 CP Guojian Pharma Biosimilar Drug Products Offered
5.1.4 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CP Guojian Pharma Biosimilar Drug Sales by Product in 2024
5.1.6 CP Guojian Pharma Biosimilar Drug Sales by Application in 2024
5.1.7 CP Guojian Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.1.8 CP Guojian Pharma Recent Developments
5.2 Biotech Pharma
5.2.1 Biotech Pharma Company Information
5.2.2 Biotech Pharma Description, Business Overview
5.2.3 Biotech Pharma Biosimilar Drug Products Offered
5.2.4 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Biotech Pharma Biosimilar Drug Sales by Product in 2024
5.2.6 Biotech Pharma Biosimilar Drug Sales by Application in 2024
5.2.7 Biotech Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.2.8 Biotech Pharma Recent Developments
5.3 Celgen Pharma
5.3.1 Celgen Pharma Company Information
5.3.2 Celgen Pharma Description, Business Overview
5.3.3 Celgen Pharma Biosimilar Drug Products Offered
5.3.4 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Celgen Pharma Biosimilar Drug Sales by Product in 2024
5.3.6 Celgen Pharma Biosimilar Drug Sales by Application in 2024
5.3.7 Celgen Pharma Biosimilar Drug Sales by Geographic Area in 2024
5.3.8 Celgen Pharma Recent Developments
5.4 Henlius
5.4.1 Henlius Company Information
5.4.2 Henlius Description, Business Overview
5.4.3 Henlius Biosimilar Drug Products Offered
5.4.4 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Henlius Biosimilar Drug Sales by Product in 2024
5.4.6 Henlius Biosimilar Drug Sales by Application in 2024
5.4.7 Henlius Biosimilar Drug Sales by Geographic Area in 2024
5.4.8 Henlius Recent Developments
5.5 Amgen
5.5.1 Amgen Company Information
5.5.2 Amgen Description, Business Overview
5.5.3 Amgen Biosimilar Drug Products Offered
5.5.4 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Amgen Biosimilar Drug Sales by Product in 2024
5.5.6 Amgen Biosimilar Drug Sales by Application in 2024
5.5.7 Amgen Biosimilar Drug Sales by Geographic Area in 2024
5.5.8 Amgen Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Company Information
5.6.2 Eli Lilly Description, Business Overview
5.6.3 Eli Lilly Biosimilar Drug Products Offered
5.6.4 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Eli Lilly Biosimilar Drug Sales by Product in 2024
5.6.6 Eli Lilly Biosimilar Drug Sales by Application in 2024
5.6.7 Eli Lilly Biosimilar Drug Sales by Geographic Area in 2024
5.6.8 Eli Lilly Recent Developments
5.7 Sandoz
5.7.1 Sandoz Company Information
5.7.2 Sandoz Description, Business Overview
5.7.3 Sandoz Biosimilar Drug Products Offered
5.7.4 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Sandoz Biosimilar Drug Sales by Product in 2024
5.7.6 Sandoz Biosimilar Drug Sales by Application in 2024
5.7.7 Sandoz Biosimilar Drug Sales by Geographic Area in 2024
5.7.8 Sandoz Recent Developments
5.8 Changchun High Tech
5.8.1 Changchun High Tech Company Information
5.8.2 Changchun High Tech Description, Business Overview
5.8.3 Changchun High Tech Biosimilar Drug Products Offered
5.8.4 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Changchun High Tech Biosimilar Drug Sales by Product in 2024
5.8.6 Changchun High Tech Biosimilar Drug Sales by Application in 2024
5.8.7 Changchun High Tech Biosimilar Drug Sales by Geographic Area in 2024
5.8.8 Changchun High Tech Recent Developments
5.9 Innovent
5.9.1 Innovent Company Information
5.9.2 Innovent Description, Business Overview
5.9.3 Innovent Biosimilar Drug Products Offered
5.9.4 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Innovent Biosimilar Drug Sales by Product in 2024
5.9.6 Innovent Biosimilar Drug Sales by Application in 2024
5.9.7 Innovent Biosimilar Drug Sales by Geographic Area in 2024
5.9.8 Innovent Recent Developments
6 North America
6.1 North America Biosimilar Drug Market Size YoY Growth 2020-2031
6.2 North America Biosimilar Drug Market Facts & Figures by Country
6.2.1 North America Biosimilar Drug Sales by Country (2020-2031)
6.2.2 North America Biosimilar Drug Revenue by Country (2020-2031)
6.3 North America Biosimilar Drug Sales by Type (2020-2025)
6.4 North America Biosimilar Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Biosimilar Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Biosimilar Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Biosimilar Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Biosimilar Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Biosimilar Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Biosimilar Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Biosimilar Drug Market Size YoY Growth 2020-2031
8.2 Europe Biosimilar Drug Market Facts & Figures by Country
8.2.1 Europe Biosimilar Drug Sales by Country (2020-2031)
8.2.2 Europe Biosimilar Drug Revenue by Country (2020-2031)
8.3 Europe Biosimilar Drug Sales by Type (2020-2025)
8.4 Europe Biosimilar Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Biosimilar Drug Market Size YoY Growth 2020-2031
9.2 Latin America Biosimilar Drug Market Facts & Figures by Country
9.2.1 Latin America Biosimilar Drug Sales by Country (2020-2031)
9.2.2 Latin America Biosimilar Drug Revenue by Country (2020-2031)
9.3 Latin America Biosimilar Drug Sales by Type (2020-2025)
9.4 Latin America Biosimilar Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Biosimilar Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Biosimilar Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Biosimilar Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Biosimilar Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Biosimilar Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Biosimilar Drug Supply Chain Analysis
11.2 Biosimilar Drug Key Raw Materials and Upstream Suppliers
11.3 Biosimilar Drug Clients Analysis
11.4 Biosimilar Drug Sales Channel and Sales Model Analysis
11.4.1 Biosimilar Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Biosimilar Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Biosimilar Drug Distributors
12 Biosimilar Drug Market Dynamics
12.1 Biosimilar Drug Industry Trends
12.2 Biosimilar Drug Market Drivers
12.3 Biosimilar Drug Market Challenges
12.4 Biosimilar Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biosimilar Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biosimilar Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 5. Global Biosimilar Drug Sales Forecast by Region (2026-2031) & (K Dose)
Table 6. Global Biosimilar Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Biosimilar Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Biosimilar Drug Sales Volume by Type (2020-2025) & (K Dose)
Table 9. Global Biosimilar Drug Sales Volume by Type (2026-2031) & (K Dose)
Table 10. Global Biosimilar Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Biosimilar Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Biosimilar Drug Sales Volume by Application (2020-2025) & (K Dose)
Table 13. Global Biosimilar Drug Sales Volume by Application (2026-2031) & (K Dose)
Table 14. Global Biosimilar Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Biosimilar Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Biosimilar Drug Sales by Manufacturer (2020-2025) & (K Dose)
Table 17. Global Biosimilar Drug Sales Share by Manufacturer (2020-2025)
Table 18. Biosimilar Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Biosimilar Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Biosimilar Drug Price (2020-2025) & (USD/Dose)
Table 21. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2024)
Table 24. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Biosimilar Drug Market
Table 26. Manufacturers Biosimilar Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CP Guojian Pharma Company Information
Table 29. CP Guojian Pharma Description and Business Overview
Table 30. CP Guojian Pharma Biosimilar Drug Product
Table 31. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 32. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 33. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 34. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 35. CP Guojian Pharma Recent Developments
Table 36. Biotech Pharma Company Information
Table 37. Biotech Pharma Description and Business Overview
Table 38. Biotech Pharma Biosimilar Drug Product
Table 39. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 40. Biotech Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 41. Biotech Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 42. Biotech Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 43. Biotech Pharma Recent Developments
Table 44. Celgen Pharma Company Information
Table 45. Celgen Pharma Description and Business Overview
Table 46. Celgen Pharma Biosimilar Drug Product
Table 47. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 48. Celgen Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 49. Celgen Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 50. Celgen Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 51. Celgen Pharma Recent Developments
Table 52. Henlius Company Information
Table 53. Henlius Description and Business Overview
Table 54. Henlius Biosimilar Drug Product
Table 55. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 56. Henlius Sales Proportion of Biosimilar Drug by Product in 2024
Table 57. Henlius Sales Proportion of Biosimilar Drug by Application in 2024
Table 58. Henlius Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 59. Henlius Recent Developments
Table 60. Amgen Company Information
Table 61. Amgen Description and Business Overview
Table 62. Amgen Biosimilar Drug Product
Table 63. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 64. Amgen Sales Proportion of Biosimilar Drug by Product in 2024
Table 65. Amgen Sales Proportion of Biosimilar Drug by Application in 2024
Table 66. Amgen Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 67. Amgen Recent Developments
Table 68. Eli Lilly Company Information
Table 69. Eli Lilly Description and Business Overview
Table 70. Eli Lilly Biosimilar Drug Product
Table 71. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 72. Eli Lilly Sales Proportion of Biosimilar Drug by Product in 2024
Table 73. Eli Lilly Sales Proportion of Biosimilar Drug by Application in 2024
Table 74. Eli Lilly Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 75. Eli Lilly Recent Developments
Table 76. Sandoz Company Information
Table 77. Sandoz Description and Business Overview
Table 78. Sandoz Biosimilar Drug Product
Table 79. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Sandoz Sales Proportion of Biosimilar Drug by Product in 2024
Table 81. Sandoz Sales Proportion of Biosimilar Drug by Application in 2024
Table 82. Sandoz Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 83. Sandoz Recent Developments
Table 84. Changchun High Tech Company Information
Table 85. Changchun High Tech Description and Business Overview
Table 86. Changchun High Tech Biosimilar Drug Product
Table 87. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Changchun High Tech Sales Proportion of Biosimilar Drug by Product in 2024
Table 89. Changchun High Tech Sales Proportion of Biosimilar Drug by Application in 2024
Table 90. Changchun High Tech Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 91. Changchun High Tech Recent Developments
Table 92. Innovent Company Information
Table 93. Innovent Description and Business Overview
Table 94. Innovent Biosimilar Drug Product
Table 95. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Innovent Sales Proportion of Biosimilar Drug by Product in 2024
Table 97. Innovent Sales Proportion of Biosimilar Drug by Application in 2024
Table 98. Innovent Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 99. Innovent Recent Developments
Table 100. North America Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 101. North America Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 102. North America Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 105. North America Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 106. Asia-Pacific Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 107. Asia-Pacific Biosimilar Drug Sales by Region (2026-2031) & (K Dose)
Table 108. Asia-Pacific Biosimilar Drug Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Biosimilar Drug Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 111. Asia-Pacific Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 112. Europe Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 113. Europe Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 114. Europe Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 117. Europe Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 118. Latin America Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 119. Latin America Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 120. Latin America Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 123. Latin America Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 124. Middle East and Africa Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 125. Middle East and Africa Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 126. Middle East and Africa Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 129. Middle East and Africa Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 130. Biosimilar Drug Key Raw Materials, Industry Status and Trend
Table 131. Biosimilar Drug Key Raw Materials and Upstream Suppliers
Table 132. Biosimilar Drug Clients Status and Trend
Table 133. Biosimilar Drug Typical Clients
Table 134. Biosimilar Drug Distributors
Table 135. Biosimilar Drug Market Trends
Table 136. Biosimilar Drug Market Drivers
Table 137. Biosimilar Drug Market Challenges
Table 138. Biosimilar Drug Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biosimilar Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Tablets Product Picture
Figure 6. Other Types Product Picture
Figure 7. Global Biosimilar Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Biosimilar Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Ankylosing Spondylitis
Figure 10. Tumor
Figure 11. Rheumatoid Arthrtis
Figure 12. Cardiovascular
Figure 13. Other Application
Figure 14. Biosimilar Drug Report Years Considered
Figure 15. Global Biosimilar Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biosimilar Drug Market Size 2020-2031 (US$ Million)
Figure 17. Global Biosimilar Drug Sales 2020-2031 (K Dose)
Figure 18. Global Biosimilar Drug Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Biosimilar Drug Revenue Market Share by Region (2020-2031)
Figure 20. Global Biosimilar Drug Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Biosimilar Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Biosimilar Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
Figure 23. Global Biosimilar Drug Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Biosimilar Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Biosimilar Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Dose)
Figure 26. Injection of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Tablets of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other Types of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Biosimilar Drug Sales Share by Manufacturer in 2024
Figure 30. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Injection Market Sales Proportion by Manufacturer in 2024
Figure 32. Tablets Market Sales Proportion by Manufacturer in 2024
Figure 33. Other Types Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Biosimilar Drug Revenue 2020-2031 (US$ Million)
Figure 35. North America Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 36. North America Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 37. Asia-Pacific Biosimilar Drug Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 42. Europe Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 44. Europe Biosimilar Drug Revenue Market Share by Country (2020-2031)
Figure 45. Europe Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 46. Europe Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 47. Latin America Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 51. Latin America Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 57. Biosimilar Drug Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Biosimilar Drug Raw Materials by Region in 2024
Figure 59. Biosimilar Drug Distribution Channels
Figure 60. Global Biosimilar Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Biosimilar Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Biosimilar Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biosimilar Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Biosimilar Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 5. Global Biosimilar Drug Sales Forecast by Region (2026-2031) & (K Dose)
Table 6. Global Biosimilar Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Biosimilar Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Biosimilar Drug Sales Volume by Type (2020-2025) & (K Dose)
Table 9. Global Biosimilar Drug Sales Volume by Type (2026-2031) & (K Dose)
Table 10. Global Biosimilar Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Biosimilar Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Biosimilar Drug Sales Volume by Application (2020-2025) & (K Dose)
Table 13. Global Biosimilar Drug Sales Volume by Application (2026-2031) & (K Dose)
Table 14. Global Biosimilar Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Biosimilar Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Biosimilar Drug Sales by Manufacturer (2020-2025) & (K Dose)
Table 17. Global Biosimilar Drug Sales Share by Manufacturer (2020-2025)
Table 18. Biosimilar Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Biosimilar Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Biosimilar Drug Price (2020-2025) & (USD/Dose)
Table 21. Ranking of Global Top Biosimilar Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2024)
Table 24. Biosimilar Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Biosimilar Drug Market
Table 26. Manufacturers Biosimilar Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. CP Guojian Pharma Company Information
Table 29. CP Guojian Pharma Description and Business Overview
Table 30. CP Guojian Pharma Biosimilar Drug Product
Table 31. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 32. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 33. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 34. CP Guojian Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 35. CP Guojian Pharma Recent Developments
Table 36. Biotech Pharma Company Information
Table 37. Biotech Pharma Description and Business Overview
Table 38. Biotech Pharma Biosimilar Drug Product
Table 39. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 40. Biotech Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 41. Biotech Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 42. Biotech Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 43. Biotech Pharma Recent Developments
Table 44. Celgen Pharma Company Information
Table 45. Celgen Pharma Description and Business Overview
Table 46. Celgen Pharma Biosimilar Drug Product
Table 47. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 48. Celgen Pharma Sales Proportion of Biosimilar Drug by Product in 2024
Table 49. Celgen Pharma Sales Proportion of Biosimilar Drug by Application in 2024
Table 50. Celgen Pharma Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 51. Celgen Pharma Recent Developments
Table 52. Henlius Company Information
Table 53. Henlius Description and Business Overview
Table 54. Henlius Biosimilar Drug Product
Table 55. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 56. Henlius Sales Proportion of Biosimilar Drug by Product in 2024
Table 57. Henlius Sales Proportion of Biosimilar Drug by Application in 2024
Table 58. Henlius Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 59. Henlius Recent Developments
Table 60. Amgen Company Information
Table 61. Amgen Description and Business Overview
Table 62. Amgen Biosimilar Drug Product
Table 63. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 64. Amgen Sales Proportion of Biosimilar Drug by Product in 2024
Table 65. Amgen Sales Proportion of Biosimilar Drug by Application in 2024
Table 66. Amgen Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 67. Amgen Recent Developments
Table 68. Eli Lilly Company Information
Table 69. Eli Lilly Description and Business Overview
Table 70. Eli Lilly Biosimilar Drug Product
Table 71. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 72. Eli Lilly Sales Proportion of Biosimilar Drug by Product in 2024
Table 73. Eli Lilly Sales Proportion of Biosimilar Drug by Application in 2024
Table 74. Eli Lilly Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 75. Eli Lilly Recent Developments
Table 76. Sandoz Company Information
Table 77. Sandoz Description and Business Overview
Table 78. Sandoz Biosimilar Drug Product
Table 79. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. Sandoz Sales Proportion of Biosimilar Drug by Product in 2024
Table 81. Sandoz Sales Proportion of Biosimilar Drug by Application in 2024
Table 82. Sandoz Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 83. Sandoz Recent Developments
Table 84. Changchun High Tech Company Information
Table 85. Changchun High Tech Description and Business Overview
Table 86. Changchun High Tech Biosimilar Drug Product
Table 87. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Changchun High Tech Sales Proportion of Biosimilar Drug by Product in 2024
Table 89. Changchun High Tech Sales Proportion of Biosimilar Drug by Application in 2024
Table 90. Changchun High Tech Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 91. Changchun High Tech Recent Developments
Table 92. Innovent Company Information
Table 93. Innovent Description and Business Overview
Table 94. Innovent Biosimilar Drug Product
Table 95. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Innovent Sales Proportion of Biosimilar Drug by Product in 2024
Table 97. Innovent Sales Proportion of Biosimilar Drug by Application in 2024
Table 98. Innovent Sales Proportion of Biosimilar Drug by Geographic Area in 2024
Table 99. Innovent Recent Developments
Table 100. North America Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 101. North America Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 102. North America Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 103. North America Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 104. North America Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 105. North America Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 106. Asia-Pacific Biosimilar Drug Sales by Region (2020-2025) & (K Dose)
Table 107. Asia-Pacific Biosimilar Drug Sales by Region (2026-2031) & (K Dose)
Table 108. Asia-Pacific Biosimilar Drug Revenue by Region (2020-2025) & (US$ Million)
Table 109. Asia-Pacific Biosimilar Drug Revenue by Region (2026-2031) & (US$ Million)
Table 110. Asia-Pacific Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 111. Asia-Pacific Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 112. Europe Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 113. Europe Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 114. Europe Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 115. Europe Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 116. Europe Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 117. Europe Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 118. Latin America Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 119. Latin America Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 120. Latin America Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 121. Latin America Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 122. Latin America Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 123. Latin America Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 124. Middle East and Africa Biosimilar Drug Sales by Country (2020-2025) & (K Dose)
Table 125. Middle East and Africa Biosimilar Drug Sales by Country (2026-2031) & (K Dose)
Table 126. Middle East and Africa Biosimilar Drug Revenue by Country (2020-2025) & (US$ Million)
Table 127. Middle East and Africa Biosimilar Drug Revenue by Country (2026-2031) & (US$ Million)
Table 128. Middle East and Africa Biosimilar Drug Sales by Type (2020-2025) & (K Dose)
Table 129. Middle East and Africa Biosimilar Drug Sales by Application (2020-2025) & (K Dose)
Table 130. Biosimilar Drug Key Raw Materials, Industry Status and Trend
Table 131. Biosimilar Drug Key Raw Materials and Upstream Suppliers
Table 132. Biosimilar Drug Clients Status and Trend
Table 133. Biosimilar Drug Typical Clients
Table 134. Biosimilar Drug Distributors
Table 135. Biosimilar Drug Market Trends
Table 136. Biosimilar Drug Market Drivers
Table 137. Biosimilar Drug Market Challenges
Table 138. Biosimilar Drug Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 2. Global Biosimilar Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Biosimilar Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Tablets Product Picture
Figure 6. Other Types Product Picture
Figure 7. Global Biosimilar Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Biosimilar Drug Sales Market Share by Application in 2024 & 2031
Figure 9. Ankylosing Spondylitis
Figure 10. Tumor
Figure 11. Rheumatoid Arthrtis
Figure 12. Cardiovascular
Figure 13. Other Application
Figure 14. Biosimilar Drug Report Years Considered
Figure 15. Global Biosimilar Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biosimilar Drug Market Size 2020-2031 (US$ Million)
Figure 17. Global Biosimilar Drug Sales 2020-2031 (K Dose)
Figure 18. Global Biosimilar Drug Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Biosimilar Drug Revenue Market Share by Region (2020-2031)
Figure 20. Global Biosimilar Drug Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Biosimilar Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Biosimilar Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
Figure 23. Global Biosimilar Drug Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Biosimilar Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Biosimilar Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Dose)
Figure 26. Injection of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Tablets of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 28. Other Types of Biosimilar Drug Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Biosimilar Drug Sales Share by Manufacturer in 2024
Figure 30. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Injection Market Sales Proportion by Manufacturer in 2024
Figure 32. Tablets Market Sales Proportion by Manufacturer in 2024
Figure 33. Other Types Market Sales Proportion by Manufacturer in 2024
Figure 34. North America Biosimilar Drug Revenue 2020-2031 (US$ Million)
Figure 35. North America Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 36. North America Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 37. Asia-Pacific Biosimilar Drug Revenue 2020-2031 (US$ Million)
Figure 38. Asia-Pacific Biosimilar Drug Sales Market Share by Region (2020-2031)
Figure 39. Asia-Pacific Biosimilar Drug Revenue Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 41. Asia-Pacific Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 42. Europe Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Europe Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 44. Europe Biosimilar Drug Revenue Market Share by Country (2020-2031)
Figure 45. Europe Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 46. Europe Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 47. Latin America Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Latin America Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Biosimilar Drug Revenue Market Share by Country (2020-2025)
Figure 50. Latin America Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 51. Latin America Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 52. Middle East and Africa Biosimilar Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 53. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2020-2025)
Figure 56. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2020-2025)
Figure 57. Biosimilar Drug Supply Chain (Upstream and Downstream Market)
Figure 58. Global Production Market Share of Biosimilar Drug Raw Materials by Region in 2024
Figure 59. Biosimilar Drug Distribution Channels
Figure 60. Global Biosimilar Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 61. Global Biosimilar Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232